Key result
Tissue-based neuroimaging identifies salvageable brain tissue and predicts neurological deterioration in minor LVO stroke.
Why the study?
Patients with minor ischemic stroke (NIHSS<=5) and anterior large vessel occlusion were markedly underrepresented in landmark thrombectomy trials, leaving limited evidence to guide endovascular thrombectomy and imaging-based patient selection despite nearly one-third experiencing poor functional outcomes.
Provides a clinical state-of-practice neuroimaging workflow using CTA and CT/MR perfusion to stratify risk of early neurological deterioration and guide treatment decisions in minor LVO stroke pending results from ongoing RCTs (STEP and MOSTE).
Answers are grounded in this paper and cite their sources.
Neuroimaging may refine risk stratification in minor LVO stroke; leaves open treatment selection until STEP and MOSTE report.
BACKGROUND: Minor ischemic stroke (MIS) with anterior large vessel occlusion (LVO) is a distinct stroke subtype in which mild neurological deficits may mask a substantial volume of threatened but salvageable brain tissue. Despite a baseline NIHSS≤5, nearly one-third of patients experience poor functional outcomes, often due to early neurological deterioration (END). CURRENT EVIDENCE AND ONGOING TRIALS: Patients with LVO-MIS were markedly underrepresented in landmark thrombectomy trials, resulting in limited evidence to guide treatment. Retrospective studies have identified imaging biomarkers of END, including proximal occlusion, clot length, collateral status, and perfusion mismatch, but the benefit of endovascular thrombectomy (EVT) remains uncertain. Ongoing randomized controlled trials, including STEP and MOSTE, are expected to define the role of EVT and imaging-based patient selection in this population. PURPOSE: To summarize the current state of neuroimaging in anterior circulation LVO-MIS and provide a practical imaging workflow and reporting checklist for diagnosis, prognostication, and treatment selection. KEY POINTS: CTA remains the primary modality for LVO detection and collateral assessment, while CT and MR perfusion identify salvageable tissue and predict END beyond baseline NIHSS. MRI further refines infarct core, perfusion deficit, and thrombus characterization. Current AI-based LVO detection tools improve stroke triage but require careful human oversight because proximal M2 and non-terminus ICA occlusions may be missed. CONCLUSION: Pending results from ongoing trials, tissue-based imaging with CTA, CT perfusion, and MR perfusion can complement clinical assessment to improve risk stratification and individualized treatment decisions. Advances in quantitative imaging and artificial intelligence are expected to further enable precision imaging-guided management of LVO-MIS.
No takes yet. Share an insight, caveat, or question.
Sriwastwa et al. (2026) conducted a review in Minor ischemic stroke (NIHSS≤5) with anterior circulation large vessel occlusion (LVO-MIS). Neuroimaging (CTA, CT perfusion, MR perfusion, MRI, AI-based LVO detection) and endovascular thrombectomy (EVT) was evaluated on LVO detection, early neurological deterioration (END) prediction, and treatment selection. Tissue-based neuroimaging (CTA, CT/MR perfusion) identifies salvageable tissue and predicts early neurological deterioration in minor LVO stroke (NIHSS≤5), where nearly one-third have poor outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: